✦ LIBER ✦

A phase II trial of paclitaxel poliglumex in recurrent or persistent ovarian or primary peritoneal cancer (EOC): A gynecologic oncology group study

✍ Scribed by Paul Sabbatini; Michael W. Sill; David O'Malley; Lisa Adler; Angeles Alvarez Secord

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II evaluation of mifepristone in

✍ Thomas F. Rocereto; William E. Brady; Mark S. Shahin; James S. Hoffman; Laurie S 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 162 KB

A phase II study of vorinostat in the tr

✍ Susan C. Modesitt; Michael Sill; James S. Hoffman; David P. Bender 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 251 KB

Phase II evaluation of dasatinib in the

✍ Russell J. Schilder; William E. Brady; Heather A. Lankes; James V. Fiorica; Mark 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 205 KB

A phase II evaluation of lapatinib in th

✍ Agustin A. Garcia; Michael W. Sill; Heather A. Lankes; Andrew K. Godwin; Robert 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 220 KB

Phase II trial of danazol in advanced, r

✍ Allan Covens; Virginia L Brunetto; Maurie Markman; James W Orr Jr.; Samuel S Len 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 72 KB

Phase II trial of nab-paclitaxel in the

✍ David S. Alberts; John A. Blessing; Lisa M. Landrum; David P. Warshal; Lainie P. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 209 KB